Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

Statin use lowers the risk of severe illness from COVID-19 by 30%

Some researchers have shared concerns about how statin use may impact COVID-19 patients, but a new meta-analysis suggests there is a significant benefit. 

Thumbnail

Atrial fibrillation outcomes have improved, but more work is still necessary to ‘stem the epidemic’

Researchers explored 43 years of data from the Framingham Heart Study.

Thumbnail

Big Ten, Pac-12 cancel 2020 season due to concerns over COVID-19, myocarditis

At this rate, will there be a 2020 college football season at all?

Thumbnail

Pupil measurements predict all-cause mortality among heart failure patients

The study's authors explored data from 870 acute heart failure patients treated at the same facility from January 2012 to December 2017.

Thumbnail

In-hospital bleeding, 30-day mortality higher among women undergoing TAVI

The study tracked nearly 700 patients who underwent TAVI at one of two facilities in Melbourne, Australia, over a ten-year period. 

Thumbnail

New 4D imaging technique could improve cardiac arrest outcomes

The team was able to generate 4D models that show exactly what occurs to a person’s heart during CPR, converting multiple 3D images into movie-like sequences.

Thumbnail

ACC: Healthcare workers ‘need Congress to act now’ and deliver COVID-19 stimulus

American College of Cardiology President Athena Poppas, MD, penned the statement, emphasizing how important it is for Congress to work together and get things done.

Thumbnail

CVS Health thriving despite COVID setback

After weathering rising costs in its health insurance business due to claims coming in from rescheduled procedures, CVS Health expects excellent 2020 earnings on the strength of its diversified business model.